ABVX News

Abivax S.A. (ABVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Abivax S.A. (ABVX) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Abivax S.A. (ABVX) Investors to Inquire about Securities Investigation

Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against ABIVAX Societe Anonyme (ABVX) Ready to Announce with Confidence?

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm

Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX)

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis